Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s Net Worth

$13.9 Million

Estimate Recalculated Nov 1, 2024 04:43AM EST

Who is Wellington Biomedical Innovation Master Investors (Cayman) II L.P.?

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include RayzeBio, Inc., and CARGO Therapeutics, Inc..

SEC CIK

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s CIK is 0001903360

Past Insider Trading and Trends

2023 was Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active year for acquiring shares with 2 total transactions. Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active month to acquire stocks was the month of August. 2023 was Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active year for disposing of shares, totalling 2 transactions. Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active month to dispose stocks was the month of August. 2023 saw Wellington Biomedical Innovation Master Investors (Cayman) II L.P. paying a total of $0.00 for 2,294,846 shares, this is the most they've acquired in one year. In 2023 Wellington Biomedical Innovation Master Investors (Cayman) II L.P. cashed out on 11,557,846 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RayzeBio, Inc. (RYZB) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.56M
—
—
1.56M
Sep 19
Form 3
—
0
—
—
0
No matching records found

CARGO Therapeutics, Inc. (CRGX) Snapshot price: $18.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
737K
—
—
737K
Nov 14
Form 3
—
0
—
—
0
No matching records found

MBX Biosciences, Inc. (MBX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.79M
—
—
1.79M
Sep 16
Form 3
—
0
—
—
0
No matching records found

Upstream Bio, Inc. (UPB) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
894.73K
—
—
894.73K
Oct 15
Form 3
—
0
—
—
0
No matching records found